s6y
Company name or ticker
Search
Sucampo Pharmaceuticals, Inc.
4
Meyenburg Jason Patrick: Statement of changes in beneficial ownership of securities
Filed
Friday, September 8, 2017
Period
Sep 6, 2017
Accession number
0001171843-17-005464
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header